What is Early Detection Cancer Screening?
Early cancer detection can mean the difference between life and death. At Sanctura, we provide state-of-the-art screening tools designed to detect cancer at the earliest possible stage.
Focusing on prevention and early intervention, we help patients optimise their health outcomes and avoid the challenges of late-stage cancer treatments. As the cost of treating advanced cancer rises, the benefit of early detection becomes even more critical.
Why Early Detection Cancer Screening Matters
The earlier cancer is detected, the higher the likelihood of improved prognosis. For example, in Stage I breast cancer, the 5-year survival rate is 98%, whereas Stage IV drops to 30%. Similar patterns are found across all cancers; this highlights the value of early screening in saving both lives and healthcare costs.
Early-stage cancer treatments are far more effective than late-stage interventions. The 5-year survival rates for Stage I cancers are dramatically higher across all types, compared to Stage IV cancers, where survival rates drop significantly.
Treating cancer at an early stage reduces the need for aggressive, expensive treatments, significantly lowering patients' healthcare costs.
Early detection often leads to less invasive treatments, allowing patients to maintain a better quality of life throughout their care journey.
Cancer Screening Categories
My Cancer IQ Test
A complete artificial intelligence (AI)-driven risk stratification analysis assesses your individual cancer risk based on a questionnaire that considers lifestyle, genetics, and medical history. This online test offers a personalised cancer risk profile, enabling you to take proactive steps.
Circulating Tumour DNA Test
Sanctura offers a revolutionary blood test that detects signals from over 50 types of cancers, even those that are asymptomatic or have no routine screening methods (such as pancreatic and ovarian cancer). Recommended for adults over 50 or those with an elevated risk of cancer, this test helps detect cancer before symptoms arise. Early detection means higher chances of effective treatment.
Genetics Panel
Sanctura offers a genetic test that screens for over 70 cancer-related gene mutations, including BRCA1/BRCA2 (for breast/ovarian cancer) and APC (colon cancer). This comprehensive test also includes an analysis of 30 cardiovascular and 14 pharmacodynamic genes, identifying risks that may have actionable treatment plans.
A detailed blood panel will evaluate:
- Tumour markers such as CEA, CA19-9, CA15-3, PSA, and AFP.
- Vitamin and mineral levels critical for immune and cellular health (zinc, magnesium, B vitamins, and iron).
- Endocrine function, including thyroid, testosterone, and oestrogen levels.
- Immune profile to identify immune imbalances that could predispose you to cancer or other chronic diseases.
Whole-body MRI offers noninvasive, radiation-free imaging that detects asymptomatic tumours as small as 5 millimetres. This cutting-edge technology identifies cancers in their earliest stages across multiple organs, even those not typically screened for by conventional methods. MRI is especially useful in detecting early signs of cancers such as kidney, brain, and bone cancers.
Skin cancer screening includes thorough mole mapping with digital dermoscopy, which can detect melanoma and other skin cancers at their earliest stages. Patients at higher risk of skin cancer can undergo regular mole mapping sessions to track changes over time.
We offer specialised screenings for various cancers based on individual risk factors:
- Colorectal and gastric cancer: Colonoscopy, endoscopy, or camera capsule endoscopy.
- Lung cancer: Low-dose CT scan for individuals at high risk.
- Prostate cancer: 3T Multiparametric MRI and PSA testing.
- Breast cancer: Mammogram, ultrasound, or MRI.
- Gynaecological cancers: Pap smear, transvaginal ultrasound, and comprehensive pelvic examination.
- Other cancers: Screening for kidney, brain, bone, and blood cancers.
An alternative to traditional colonoscopy, the capsule camera endoscopy allows for non-invasive visualisation of the gastrointestinal tract to detect polyps or tumours.
Recommended for individuals at high risk of lung cancer, particularly smokers or those with a history of smoking, this scan is designed to detect lung cancer early, when treatment is most effective.
Non-invasive colorectal cancer screening options that detect bleeding in the colon and other early cancer markers.